ANIP

ANIP Total Non-Current Liabilities

$613.25MQuarterly · USD

Period ending:

ANIP FY Total Non-Current LiabilitiesUSD
ANIP FY Total Non-Current Liabilities1998-12-31: $0.001999-12-31: $0.002000-12-31: $0.002001-12-31: $0.002002-12-31: $0.002003-12-31: $0.002004-12-31: $0.002005-12-31: $89.68K2006-12-31: $0.002007-12-31: $0.002008-12-31: $0.002009-12-31: $16.68M2010-12-31: $17.44M2011-12-31: $17.34M2012-12-31: $0.002013-12-31: $0.002014-12-31: $110.69M2015-12-31: $113.43M2016-12-31: $121.27M2017-12-31: $198.15M2018-12-31: $67.79M2019-12-31: $182.32M2020-12-31: $186.93M2021-12-31: $325.32M2022-12-31: $322.11M2023-12-31: $301.35M2024-12-31: $661.49M2025-12-31: $621.54M$661.49M$0.00
1998-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

ANIP total non-current liabilities history

Long-term obligations due beyond one year. The available annual fiscal periods series contains 28 observations from Dec 31, 1998 to Dec 31, 2025.

Ani Pharmaceuticals Inc Total Non-Current Liabilities — Annual fiscal periods (USD)
Period endingTotal Non-Current Liabilities (USD)
621,541,000
661,487,000
301,346,000
322,108,000
325,321,000
186,925,000
182,322,000
67,792,000
198,154,000
121,268,000
113,427,000
110,691,000
0
0
17,336,760
17,436,201
16,676,417
0
0
0
89,682
0
0
0
0
0
0
0

Compare total non-current liabilities

All ANIP financial metrics · ANIP stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.